Hjem › Endokrine sygdomme › Texas
Endokrine sygdomme kliniske forsøg i Texas
7 studier for Endokrine sygdomme søger deltagere på steder i Texas.
Byer i Texas
Officiel studietekst (engelsk)
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
- Ascendis Pharma Investigational Site, Edinburg
- Ascendis Pharma Investigational Site, Fort Worth
- Ascendis Pharma Investigational Site, San Antonio
- og 1 flere
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 30. sep. 2026 · NCT07221851A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
- Ascendis Pharma Investigational Site, Houston
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07081997A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
- VIP Trials, San Antonio
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07595549Study of BHV-1300 in Graves' Disease
- Site-109, Dallas
- Site-106, Houston
- Site-101, Houston
- og 1 flere
RekruttererFase 1
Alder 18 til 65 · Alle køn · Opdateret 31. jul. 2026 · NCT06980649A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- UT Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 27. maj 2026 · NCT03093116Rare and Atypical Diabetes Network
- Baylor College of Medicine, Houston
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 14. aug. 2025 · NCT05544266Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease
- University of Texas MD Anderson Cancer Center, Houston
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 17. sep. 2019 · NCT03050762Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.